Transarterial chemoembolization versus radioembolization as a treatment option for single large (>5 cm) hepatocellular carcinoma: a retrospective study in South Korea
Life Cycle · 2023
DOI: 10.54724/lc.2023.e13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Cycle, 2023. Verfasst von Kwanjoo Lee und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CHA University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- CHA University
Zitieren
APA
Lee, K., Lee, J. S., & Kim, D. Y. (2023). Transarterial chemoembolization versus radioembolization as a treatment option for single large (>5 cm) hepatocellular carcinoma: a retrospective study in South Korea. Life Cycle. https://doi.org/10.54724/lc.2023.e13
Vancouver
Lee K, Lee JS, Kim DY. Transarterial chemoembolization versus radioembolization as a treatment option for single large (>5 cm) hepatocellular carcinoma: a retrospective study in South Korea. Life Cycle. 2023. doi:10.54724/lc.2023.e13
BibTeX
@article{Lee2023,
author = {Lee, Kwanjoo and Lee, Jae Seung and Kim, Do Young},
title = {Transarterial chemoembolization versus radioembolization as a treatment option for single large (>5 cm) hepatocellular carcinoma: a retrospective study in South Korea},
journal = {Life Cycle},
year = {2023},
doi = {10.54724/lc.2023.e13}
}
EUVIMED